Isabelle Seguin

1.1k total citations
13 papers, 943 citations indexed

About

Isabelle Seguin is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Isabelle Seguin has authored 13 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Isabelle Seguin's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Isabelle Seguin is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Isabelle Seguin collaborates with scholars based in Canada, United States and Netherlands. Isabelle Seguin's co-authors include D. William Cameron, Curtis Cooper, Mary L. Morris, Heather L. Davis, Jonathan B. Angel, Yasmin Khaliq, Neera Singhal, Charles la Porte, Guijun Zhang and Nha Voduc and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Molecules.

In The Last Decade

Isabelle Seguin

13 papers receiving 900 citations

Peers

Isabelle Seguin
Alonso Heredia United States
Matteo Mombelli Switzerland
Ranjit Banerjee United States
Mahboob Qureshi Japan
Maria Mamani‐Matsuda France
Yonghong Feng China
S Looareesuwan Thailand
Simona Anticoli Italy
Nicola Caporaso Italy
Amre Nasr Saudi Arabia
Alonso Heredia United States
Isabelle Seguin
Citations per year, relative to Isabelle Seguin Isabelle Seguin (= 1×) peers Alonso Heredia

Countries citing papers authored by Isabelle Seguin

Since Specialization
Citations

This map shows the geographic impact of Isabelle Seguin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Seguin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Seguin more than expected).

Fields of papers citing papers by Isabelle Seguin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Seguin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Seguin. The network helps show where Isabelle Seguin may publish in the future.

Co-authorship network of co-authors of Isabelle Seguin

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Seguin. A scholar is included among the top collaborators of Isabelle Seguin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Seguin. Isabelle Seguin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ghannad, Mona, Michelle K. Dennehy, Charles la Porte, et al.. (2019). A drug interaction study investigating the effect of Rifabutin on the pharmacokinetics of Maraviroc in healthy subjects. PLoS ONE. 14(10). e0223969–e0223969. 5 indexed citations
2.
Sheehan, Nancy L., Rolf P. G. van Heeswijk, Brian C. Foster, et al.. (2012). The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients. Molecules. 17(1). 688–702. 13 indexed citations
3.
Porte, Charles la, Nha Voduc, Guijun Zhang, et al.. (2010). Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects. Clinical Pharmacokinetics. 49(7). 449–454. 213 indexed citations
4.
Cooper, Curtis, Jonathan B. Angel, Isabelle Seguin, H. L. Davis, & D. William Cameron. (2008). CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 Years. Clinical Infectious Diseases. 46(8). 1310–1314. 88 indexed citations
5.
Campbell, P A, et al.. (2006). Time‐Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine. The Journal of Clinical Pharmacology. 46(7). 758–767. 56 indexed citations
6.
Cooper, Curtis, Heather L. Davis, Jonathan B. Angel, et al.. (2005). CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS. 19(14). 1473–1479. 162 indexed citations
7.
Heeswijk, Rolf P. G. van, Curtis Cooper, Brian C. Foster, et al.. (2005). Effect of High‐Dose Vitamin C on Hepatic Cytochrome P450 3A4 Activity. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(12). 1725–1728. 10 indexed citations
8.
Heeswijk, Rolf P. G. van, et al.. (2005). Absence of circadian variation in the pharmacokinetics of lopinavir/ritonavir given as a once daily dosing regimen in HIV‐1‐infected patients. British Journal of Clinical Pharmacology. 59(4). 398–404. 10 indexed citations
9.
Cooper, Curtis, Heather L. Davis, Mary L. Morris, et al.. (2004). Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine. 22(23-24). 3136–3143. 209 indexed citations
10.
Heeswijk, Rolf P. G. van, Yasmin Khaliq, Keith Gallicano, et al.. (2004). The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clinical Pharmacology & Therapeutics. 76(6). 588–597. 54 indexed citations
11.
Khaliq, Yasmin, Keith Gallicano, Isabelle Seguin, et al.. (2000). Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus‐infected patients with chronic liver disease. British Journal of Clinical Pharmacology. 50(2). 108–115. 49 indexed citations
12.
Gallicano, Keith, Jan Sahai, Vijay K. Shukla, et al.. (1999). Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV‐infected patients. British Journal of Clinical Pharmacology. 48(2). 168–179. 66 indexed citations
13.
Gallicano, Keith, et al.. (1995). Effect of Rifabutin on the Pharmacokinetics of Zidovudine in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 21(4). 1008–1008. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alonso Heredia Breakdown of academic impact, for papers by Matteo Mombelli Breakdown of academic impact, for papers by Ranjit Banerjee Breakdown of academic impact, for papers by Mahboob Qureshi Breakdown of academic impact, for papers by Maria Mamani‐Matsuda Breakdown of academic impact, for papers by Yonghong Feng Breakdown of academic impact, for papers by S Looareesuwan Breakdown of academic impact, for papers by Simona Anticoli Breakdown of academic impact, for papers by Nicola Caporaso Breakdown of academic impact, for papers by Amre Nasr
Rankless by CCL
2026